Bell Ann V
Department of Sociology, University of Delaware, USA.
Sociol Health Illn. 2017 Nov;39(8):1480-1495. doi: 10.1111/1467-9566.12607. Epub 2017 Aug 16.
It is well established that the drivers of medicalisation have shifted alongside changes in the institution of medicine. The process of medicalisation is no longer incited by macro processes of institutional prestige or control; rather, individual patients/consumers are pushing the process forward. The present study complicates this neat transition and examines the relationship between structure and agency using the case of assisted reproductive technology (ART), specifically the medicalisation of lesbian reproduction in the US. I explore individuals' influence on and motivations towards medicalisation through 24 in-depth interviews with women in same-sex relationships who had ever attempted to become pregnant. In centring on their experiences, I find that while individual consumers may now propel medicalisation forward, oftentimes consumers' motivations for doing so reside in the prestige and control of medicine. In other words, consumers now seek medicalisation precisely because of the process's previous institutional drivers. In exploring what fuels the engine of medicalisation, the findings reveal its nuance and complexity.
人们普遍认为,医学化的驱动因素已随着医学机构的变化而发生转变。医学化过程不再是由机构声望或控制的宏观过程所引发;相反,个体患者/消费者正在推动这一过程向前发展。本研究使这一简单的转变变得复杂,并以辅助生殖技术(ART)为例,特别是美国女同性恋者生育的医学化,来考察结构与能动性之间的关系。我通过对24名有过尝试怀孕经历的同性关系女性进行深入访谈,探讨了个体对医学化的影响及其动机。以她们的经历为中心,我发现虽然个体消费者现在可能推动医学化向前发展,但消费者这样做的动机往往在于医学的声望和控制。换句话说,消费者现在寻求医学化恰恰是因为这一过程先前的机构驱动因素。在探究推动医学化引擎的因素时,研究结果揭示了其细微差别和复杂性。